Since its inception in 1998, the lung transplant program at The Ohio State University has continued to offer hope for patients afflicted with end-stage lung disease. When all other therapeutic options are exhausted, lung transplantation frequently provides an alternative for a wide range of patients in both the adult and pediatric age groups. Transplantation has been shown to improve quality of life, functional endurance, exercise tolerance, and survival in select patient groups.
Today, lung transplantation is considered a viable treatment for many patients with most transplants being performed for end-stage lung disease resulting from emphysema, pulmonary fibrosis, and cystic fibrosis. Additionally, other lung diseases such as those resulting from sarcoidosis, collagen vascular disorders, and pulmonary hypertension are also amenable to this therapy.
The lung transplant team is under the direction of chief surgeon Dr. Patrick Ross and medical pulmonologists Dr. Amy Pope-Harman and Dr. David Nunley.
For more information about the lung transplant program at The Ohio State University, contact the OSU Lung Transplant office at 614-293-5822.
Links of interest: